Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.

Liver international : official journal of the International Association for the Study of the Liver - 1 Jun 2015

Torres Harrys A, Mahale Parag

Abstract excerpt

BACKGROUND & AIMS: Hepatitis C virus (HCV) is associated with development of B-cell non-Hodgkin lymphoma (HCV-NHL). Antiviral therapy (AVT) is prioritized in HCV-infected patients with significant fibrosis/cirrhosis. It is unknown whether current recommendations based on liver parameters cover the risk of HCV-NHL development. We aimed to evaluate the liver disease stages of patients with HCV-NHL. METHODS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Liver Cirrhosis

Share to Lymphoma, Non-Hodgkin

Source

Identifiers

PMID: 25779000
DOI: 10.1111/liv.12825

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Most patients with HCV-associated lymphoma present with mild liver disease: a call to revise antiviral treatment prioritization.PMID 25779000Read ↗

Elbasvir/Grazoprevir combination therapy in a B-NHL patient with HCV genotype 1 infection.Semantic proximity Read ↗

Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.Semantic proximity Read ↗

Hepatitis C Virus-Associated Non-Hodgkin Lymphomas: Biology, Epidemiology, and Treatment.Semantic proximity Read ↗

Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.Semantic proximity Read ↗

Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.Semantic proximity Read ↗

Hepatitis C virus and lymphoma.Semantic proximity Read ↗

Management of hepatitis C positive patients undergoing active treatment for malignancies: A position paper from the Associazione Italiana di Oncologia Medica (AIOM) and the Società Italiana di Malattie Infettive e Tropicali (SIMIT).Semantic proximity Read ↗

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.Semantic proximity Read ↗

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study.Semantic proximity Read ↗

Hepatitis C Virus Infection and Risk of Non-Hodgkin’s Lymphoma: A Case-control Study in Mainland ChinaSemantic proximity Read ↗

Molecular characterization of diffuse large B-cell lymphomas associated with hepatitis C virus infection.Semantic proximity Read ↗

The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.